OpenAI researchers released Genebench-Pro, a specialized benchmark evaluating AI models on complex genomic reasoning tasks. The system presents 10 detailed case studies spanning cancer therapy decisions, CRISPR validation, and population genetics analysis, each requiring models to interpret genetic data and make evidence-based conclusions.

The benchmark challenges models with real-world genomics problems like estimating tumor therapy benefits from structural variants, validating CRISPR targets against locus effects, and mapping quantitative trait loci in multi-parent populations. Each case study provides curated datasets including registry covariates, screening rosters, and single-cell RNA-seq counts.

Researchers designed these scenarios to test whether AI systems can handle technical complexities inherent in genomic analysis. Tasks require managing confounding factors like ambient RNA contamination, mapping artifacts, and population stratification while maintaining statistical rigor.

Genebench-Pro establishes rigorous evaluation standards for AI in computational biology, potentially accelerating drug discovery and precision medicine applications where accurate genetic interpretation remains critical.